NEW YORK (GenomeWeb News) – Shares in Molecular Devices were up around 10 percent, or $2.17, to $24.39 in mid-afternoon trading today after an investment bank yesterday upgraded its stock.
 
Infinium Securities upgraded the stock to “Outperform” from “Underperform” yesterday.
 
The uptick today halted a 16-percent decline in share price that began July 21 when Molecular Devices announced weak second quarter revenue and earnings.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.